Webinar: High-Throughput Developability Assessment of Therapeutic Antibody Candidates in Discovery Stage

Relive our June 20th webinar! Instant Replay

Events

SDBN “Lunch On Us” Event

May 21
San Diego, CA

BioTalk US

May 22-23
Boston, MA

Press Releases

5.8.2019

GVK BIO announces the appointment of Axel Schleyer, Ph.D. as Chief Executive Officer, Aragen Bioscience, Inc.

3.19.2018

Aragen Bioscience Expands RapTr Cell Line Development Services

11.10.2017
Aragen Bioscience Announces AAALAC Accreditation

06.20.2017
RapTr Cell Line Development Services Introduced